Dimopoulos, M.A. Cavo, M. Mateos, M.-V. Facon, T. Heeg, B. van Beekhuizen, S. Gebregergish, S.B. Nair, S. Pisini, M. Lam, A. Slavcev, M., A matching-adjusted indirect treatment comparison (MAIC) of daratumumab–bortezomib–melphalan–prednisone (D-VMP) versus lenalidomide–dexamethasone continuous (Rd continuous), lenalidomide–dexamethasone 18 months (Rd 18), and melphalan–prednisone–thalidomide (MPT), Clinical Lymphoma Myeloma and Leukemia, (61), 714-720, 2020, Taylor and Francis Ltd.,